GLUE fundamentals
Monte Rosa Therapeutics, Inc. earnings per share and revenue
GLUE earnings per share for the last quarter are 0.57 USD whereas the estimation was -0.00 USD which accounts for 21674.56% surprise. Company revenue for the same period amounts to 84.93 M USD despite the estimated figure of 41.68 M USD. Estimated earnings per share for the next quarter are -0.38 USD, and revenue is expected to reach 7.38 M USD. Also watch annual changes over time to get a bigger picture of GLUE earnings per share and revenue dynamics.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise